Facing the Challenges of Industrial Scale-Up in Medical Devices: Innate’s Experience

The industrial scale-up process in the medical device sector represents a crucial challenge for companies that want to take a product from the development phase to full-scale production. This transition is not just a matter of increasing production capacity, but involves strict quality management, compliance with regulatory standards and process optimisation to ensure efficiency and safety.
In this context, Innate stands out for its ability to tackle the complexities of the industry with a strategic and innovative approach.

Through a combination of experience, advanced technology and close collaboration with customers, Innate has developed a scale-up model that ensures the industrial success of highly complex medical products such as ampoules and pre-filled syringes.

The Main Challenges of Industrial Scale-Up

The scale-up process involves a number of technical and operational hurdles that need to be addressed competently and accurately.
Key challenges include:

– Ingredient selection: Not all ingredients can be industrially scaled-up without altering their stability and efficacy. For example, hyaluronic acid and recombinant collagen must be processed using specific methods to maintain their properties.
– Regulatory compliance: Moving towards MDR (Medical Device Regulation) certification requires strict quality control and extensive testing to ensure product safety and efficacy.
– Optimisation of the production process: From the development phase to industrial production, it is essential to ensure product repeatability and uniformity, minimising variations between batches.
– Sterilisation and packaging: Many devices, such as pre-filled syringes, must withstand sterilisation processes at high temperatures without compromising their physical and functional characteristics.

Innate’s Approach to Industrial Scale-Up.
From Idea to Production: A Structured Process

Innate supports its industrial partners, in the case of CDMO projects, throughout the entire development cycle, from product conception to full-scale production.
Even in the case of the production of our branded products, this integrated approach allows time and resources to be optimised, guaranteeing a final product that meets the highest quality standards.
– Initial phase: Collaboration with the customer or our R&D to identify the best active ingredient, defining the molecular weight and formulation specifications.
– Prototyping: Creating a laboratory model and conducting initial stability tests.
– Industrial scale-up: Production of pilot batches, validation with external laboratories and quality control according to GMP and ISO 13485.

Innovation in Production: Pre-Filled Syringes and New Technologies

One of Innate’s main strengths is its expertise in the production of pre-filled syringes, a growing segment in the medical industry.
Innate has faced and overcome critical challenges, such as the need to:
✅ Finding materials compatible with 121°C autoclave sterilisation, without altering the properties of the formulation.
✅ Optimise compatibility between the injected gel and packaging materials, reducing the risk of contamination.
✅ Improve safety during application, avoiding problems such as needle detachment or variations in dosage.

The Importance of Strategic Collaborations

Innate has built its success on a network of strategic collaborations with suppliers and technology partners. This approach has optimised supply chain management and ensured production continuity even during the most critical periods, such as during the COVID-19 emergency.
In particular, Innate works closely with:
🔹 Certified suppliers, to guarantee the quality of raw materials.
🔹 External laboratories, to validate biocompatibility and stability tests.
🔹 Industrial partners, to integrate new technologies and improve production processes.

Conclusions: Scale-Up As Growth Opportunity

Meeting the challenges of industrial scale-up requires innovation, precision and a strong focus on quality.
Innate, with its experience and advanced technologies, has managed to turn these challenges into opportunities, developing cutting-edge solutions for the medical device industry.
The combination of technological know-how, investment in R&D and strategic partnerships has enabled Innate to expand globally, consolidating its position in key markets such as Europe, MENA, CIS, APAC and LATAM.
With an ongoing focus on safety, innovation and regulatory compliance, Innate is poised to lead the future of industrial scale-up in the medical sector, offering reliable, customisable and state-of-the-art solutions for its customers.